Yahoo! Health News: Oncolytics lung cancer drug shrinks tumors in 92 percent of patients in trial

Oncolytics lung cancer drug shrinks tumors in 92 percent of patients in trial

(Reuters) - Oncolytics Biotech Inc said its cancer drug Reolysin reduced the size of tumors in 92 percent of lung cancer patients in a mid-stage trial...

Source: http://health.yahoo.net/news/s/nm/oncolytics-lung-cancer-drug-shrinks-tumors-in-92-percent-of-patients-in-trial